Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  HIV Infection

  Free Subscription


03.09.2018

3 AIDS
3 AIDS Res Hum Retroviruses
1 Antimicrob Agents Chemother
1 Blood
9 Clin Infect Dis
7 HIV Med
1 Int J Dermatol
2 J Acquir Immune Defic Syndr
1 J Clin Invest
3 J Infect Dis
2 J Virol
2 Lancet
4 Lancet Child Adolesc Health
1 Lancet Infect Dis
1 N Engl J Med
1 Nature
2 Pediatr Infect Dis J
1 PLoS Biol
1 PLoS Comput Biol
1 PLoS Med
20 PLoS One
2 PLoS Pathog
1 Proc Natl Acad Sci U S A
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. SHARMA P, McCarty TR, Ngu JN, O'Donnell M, et al
    Impact of bariatric surgery in patients with HIV infection: a nationwide inpatient sample analysis, 2004-2014.
    AIDS. 2018;32:1959-1965.
    PubMed     Text format     Abstract available

  2. EMONTS M, Waalewijn H, Colbers A, Pickering A, et al
    First reported use of zidovudine for prevention of perinatal HIV transmission in a premature neonate on extra corporal membrane oxygenation.
    AIDS. 2018;32:2084-2085.
    PubMed     Text format    

  3. BURGESS PI, Harding SP, Kayange PC, van Oosterhout J, et al
    High mortality in subjects with both diabetes and HIV in sub-Saharan Africa.
    AIDS. 2018;32:2083-2084.
    PubMed     Text format    


    AIDS Res Hum Retroviruses

  4. LIU W, Feng Y, Wang C, Wang Y, et al
    Identification of a Novel HIV Type 1 CRF01_AE/CRF07_BC Recombinant virus in Men Who Have Sex with Men in GuangXi, China.
    AIDS Res Hum Retroviruses. 2018 Aug 28. doi: 10.1089/AID.2018.0157.
    PubMed     Text format     Abstract available

  5. BROWN K, Stewart L, Whitcomb J, Yang D, et al
    Prevalence of darunavir resistance in the United States from 2010 to 2017.
    AIDS Res Hum Retroviruses. 2018 Aug 27. doi: 10.1089/AID.2018.0100.
    PubMed     Text format     Abstract available

  6. FRIGATI L, Jao J, Mahtab S, Asafu Agyei NA, et al
    Insulin Resistance in South African Youth Living with Perinatally Acquired HIV Receiving Antiretroviral Therapy.
    AIDS Res Hum Retroviruses. 2018 Aug 29. doi: 10.1089/AID.2018.0092.
    PubMed     Text format     Abstract available


    Antimicrob Agents Chemother

  7. BANDA CG, Dzinjalamala F, Mukaka M, Mallewa J, et al
    Impact of efavirenz, ritonavir-boosted lopinavir and nevirapine based antiretroviral regimens on the pharmacokinetics of lumefantrine and safety of artemether-lumefantrine in falciparum-negative HIV-infected Malawian adults stabilized on antiretrovira
    Antimicrob Agents Chemother. 2018 Aug 27. pii: AAC.01162.
    PubMed     Text format     Abstract available


    Blood

  8. SHIMADA K, Hayakawa F, Kiyoi H
    Biology and management of primary effusion lymphoma.
    Blood. 2018 Aug 28. pii: blood-2018-03-791426. doi: 10.1182/blood-2018-03-791426
    PubMed     Text format     Abstract available


    Clin Infect Dis

  9. ZHAO Y, Fox T, Manning K, Stewart A, et al
    Improved treatment outcomes with bedaquiline when substituted for second-line injectable agents in multidrug resistant tuberculosis: a retrospective cohort study.
    Clin Infect Dis. 2018 Aug 24. pii: 5079132. doi: 10.1093.
    PubMed     Text format     Abstract available

  10. GUIMARAES AO, Cao Y, Hong K, Mayba O, et al
    A prognostic model of persistent bacteremia and mortality in complicated S. aureus bloodstream infection.
    Clin Infect Dis. 2018 Aug 25. pii: 5079279. doi: 10.1093.
    PubMed     Text format     Abstract available

  11. MARRA E, Siegenbeek van Heukelom ML, Leeman A, Waterboer T, et al
    Virological and serological predictors of anal high-grade squamous intraepithelial lesions among HIV-positive men who have sex with men.
    Clin Infect Dis. 2018 Aug 28. pii: 5084856. doi: 10.1093.
    PubMed     Text format     Abstract available

  12. MCMANUS KA, McManus K, Dillingham R
    National Survey of United States Human Immunodeficiency Virus Medical Providers' Knowledge and Attitudes About the Affordable Care Act.
    Clin Infect Dis. 2018 Aug 25. pii: 5033794. doi: 10.1093.
    PubMed     Text format     Abstract available

  13. STECHER M, Hoenigl M, Eis-Hubinger AM, Lehmann C, et al
    Hotspots of Transmission Driving the Local Hiv Epidemic in the Cologne-Bonn Region, Germany.
    Clin Infect Dis. 2018 Aug 29. pii: 5086115. doi: 10.1093.
    PubMed     Text format     Abstract available

  14. BEARDSLEY J, Hoang NLT, Kibengo FM, Tung NLN, et al
    Do intra-cerebral cytokine responses explain the harmful effects of dexamethasone in HIV-associated cryptococcal meningitis?
    Clin Infect Dis. 2018 Aug 30. pii: 5087661. doi: 10.1093.
    PubMed     Text format     Abstract available

  15. MARRA E, Kovaleva A, Bruisten SM, Vermeulen W, et al
    Incidence and clearance of anal high-risk HPV infection and their determinants among HIV-negative men who have sex with men over a period up to five-years.
    Clin Infect Dis. 2018 Aug 30. pii: 5087759. doi: 10.1093.
    PubMed     Text format     Abstract available

  16. DESIR FA, Lesko CR, Moore RD, Horberg MA, et al
    One Size Fits (n)One: The Influence of Sex, Age, and Sexual Human Immunodeficiency Virus (HIV) Acquisition Risk on Racial/Ethnic Disparities in the HIV Care Continuum in the United States.
    Clin Infect Dis. 2018 Aug 31. pii: 5088403. doi: 10.1093.
    PubMed     Text format     Abstract available

  17. STEIN CM, Nsereko M, Malone LL, Okware B, et al
    Long-term stability of resistance to latent M. tuberculosis infection in highly exposed TB household contacts in Kampala, Uganda.
    Clin Infect Dis. 2018 Aug 28. pii: 5085255. doi: 10.1093.
    PubMed     Text format     Abstract available


    HIV Med

  18. JASPAL R, Lopes B, Bayley J, Papaloukas P, et al
    A structural equation model to predict pre-exposure prophylaxis acceptability in men who have sex with men in Leicester, UK.
    HIV Med. 2018 Aug 30. doi: 10.1111/hiv.12667.
    PubMed     Text format     Abstract available

  19. DEWAR C, Anstee QM, Price DA, Payne B, et al
    Central obesity and nonalcoholic fatty liver disease in people living with HIV: a case for targeted screening?
    HIV Med. 2018 Aug 30. doi: 10.1111/hiv.12674.
    PubMed     Text format    

  20. FENTON K, Cropp A, Chauhan M, Foster K, et al
    Earlier diagnosis of HIV infection through visual HIV testing prompts.
    HIV Med. 2018 Aug 30. doi: 10.1111/hiv.12673.
    PubMed     Text format    

  21. RONIT A, Benfield T, Mocroft A, Gerstoft J, et al
    Diagnostic performance of clinical characteristics to detect airflow limitation in people living with HIV and in uninfected controls.
    HIV Med. 2018 Aug 30. doi: 10.1111/hiv.12669.
    PubMed     Text format     Abstract available

  22. KIEFER EM, Hoover DR, Shi Q, Dusingize JC, et al
    Longitudinal evaluation of markers of inflammation in HIV-positive and HIV-negative Rwandan women.
    HIV Med. 2018 Aug 30. doi: 10.1111/hiv.12665.
    PubMed     Text format     Abstract available

  23. THUDIUM RF, Lundgren J, Benfield T, Nordestgaard BG, et al
    HIV infection is independently associated with a higher concentration of alpha-1 antitrypsin.
    HIV Med. 2018 Aug 30. doi: 10.1111/hiv.12666.
    PubMed     Text format     Abstract available

  24. AURPIBUL L, Sugandhavesa P, Srithanaviboonchai K, Sitthi W, et al
    Peripheral artery disease in HIV-infected older adults on antiretroviral treatment in Thailand.
    HIV Med. 2018 Aug 30. doi: 10.1111/hiv.12671.
    PubMed     Text format     Abstract available


    Int J Dermatol

  25. MADU PN, Williams VL, Noe MH, Omech BG, et al
    Autoimmune skin disease among dermatology outpatients in Botswana: a retrospective review.
    Int J Dermatol. 2018 Aug 31. doi: 10.1111/ijd.14201.
    PubMed     Text format     Abstract available


    J Acquir Immune Defic Syndr

  26. GICHANGI A, Wambua J, Mutwiwa S, Njogu R, et al
    Impact of HIV Self-Test Distribution to Male Partners of ANC Clients: Results of a Randomized Controlled Trial in Kenya.
    J Acquir Immune Defic Syndr. 2018 Aug 16. doi: 10.1097/QAI.0000000000001838.
    PubMed     Text format     Abstract available

  27. AMMASSARI A, Stohr W, Antinori A, Molina JM, et al
    Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined with Either Raltegravir or Tenofovir Disoproxil Fumarate /Emtricitabine in the Neat 001/Anrs 143 Trial.
    J Acquir Immune Defic Syndr. 2018 Aug 27. doi: 10.1097/QAI.0000000000001834.
    PubMed     Text format     Abstract available


    J Clin Invest

  28. CHENG L, Wang Q, Li G, Banga R, et al
    TLR3 agonist and CD40-targeting vaccination induces immune responses and reduces HIV-1 reservoirs.
    J Clin Invest. 2018 Aug 27. pii: 99005. doi: 10.1172/JCI99005.
    PubMed     Text format     Abstract available


    J Infect Dis

  29. SCHWETZ TA, Fauci AS
    The Extended Impact of Human Immunodeficiency Virus/AIDS Research.
    J Infect Dis. 2018 Aug 28. pii: 5063659. doi: 10.1093.
    PubMed     Text format     Abstract available

  30. LEDDY AM, Roque A, Sheira LA, Frongillo EA, et al
    Food insecurity is associated with inflammation among women living with HIV.
    J Infect Dis. 2018 Aug 27. pii: 5080937. doi: 10.1093.
    PubMed     Text format     Abstract available

  31. LETIZIA A, Eller MA, Polyak C, Eller LA, et al
    Biomarkers of Inflammation Correlate with Clinical Scoring Indices in HIV-Infected Kenyans.
    J Infect Dis. 2018 Aug 27. pii: 5082069. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Virol

  32. SHARMA S, Lewinski MK, Guatelli J
    An N-glycosylated form of SERINC5 is specifically incorporated into HIV-1 virions.
    J Virol. 2018 Aug 29. pii: JVI.00753-18. doi: 10.1128/JVI.00753.
    PubMed     Text format     Abstract available

  33. TEODOROF-DIEDRICH C, Spector SA
    Human Immunodeficiency Virus Type-1 gp120 and Tat Induce Mitochondrial Fragmentation and Incomplete Mitophagy in Human Neurons.
    J Virol. 2018 Aug 29. pii: JVI.00993-18. doi: 10.1128/JVI.00993.
    PubMed     Text format     Abstract available


    Lancet

  34. BELETSKY L, Baker P, Arredondo J, Emuka A, et al
    The global health and equity imperative for safe consumption facilities.
    Lancet. 2018;392:553-554.
    PubMed     Text format    

  35. MCCALL B
    Scientific evidence against HIV criminalisation.
    Lancet. 2018;392:543-544.
    PubMed     Text format    


    Lancet Child Adolesc Health

  36. STRAUB DM, Tanner AE
    Health-care transition from adolescent to adult services for young people with HIV.
    Lancet Child Adolesc Health. 2018;2:214-222.
    PubMed     Text format     Abstract available

  37. NWAOHIRI A, Schillie S, Bulterys M, Kourtis AP, et al
    Towards elimination of hepatitis C virus infection in children.
    Lancet Child Adolesc Health. 2018;2:235-237.
    PubMed     Text format    

  38. PRATICO L, Pizzol D
    Health-care services for young people with HIV in Mozambique.
    Lancet Child Adolesc Health. 2018;2:e12.
    PubMed     Text format    

  39. KINGHORN A, Shanaube K, Toska E, Cluver L, et al
    Defining adolescence: priorities from a global health perspective.
    Lancet Child Adolesc Health. 2018;2:e10.
    PubMed     Text format    


    Lancet Infect Dis

  40. ADENIS AA, Valdes A, Cropet C, McCotter OZ, et al
    Burden of HIV-associated histoplasmosis compared with tuberculosis in Latin America: a modelling study.
    Lancet Infect Dis. 2018 Aug 23. pii: S1473-3099(18)30354.
    PubMed     Text format     Abstract available


    N Engl J Med

  41. SHAH NN, Singavi AK, Harrington A
    Daratumumab in Primary Effusion Lymphoma.
    N Engl J Med. 2018;379:689-690.
    PubMed     Text format    


    Nature

  42. DICK RA, Zadrozny KK, Xu C, Schur FKM, et al
    Author Correction: Inositol phosphates are assembly co-factors for HIV-1.
    Nature. 2018 Aug 29. pii: 10.1038/s41586-018-0505.
    PubMed     Text format     Abstract available


    Pediatr Infect Dis J

  43. TRAHAN MJ, Lamarre V, Metras ME, Kakkar F, et al
    Use of Triple Combination Antiretroviral Therapy With Raltegravir as Empiric HIV Therapy in the High-Risk HIV-Exposed Newborn.
    Pediatr Infect Dis J. 2018 Aug 27. doi: 10.1097/INF.0000000000002180.
    PubMed     Text format     Abstract available

  44. FRIGATI L, Bekker A, Stroebele S, Goussard P, et al
    Culture-Confirmed Tuberculosis in South African Infants Younger Than 3 Months of Age: Clinical Presentation and Management of Respiratory Complications.
    Pediatr Infect Dis J. 2018 Aug 27. doi: 10.1097/INF.0000000000002163.
    PubMed     Text format     Abstract available


    PLoS Biol

  45. BYRNE G, O'Rourke SM, Alexander DL, Yu B, et al
    CRISPR/Cas9 gene editing for the creation of an MGAT1-deficient CHO cell line to control HIV-1 vaccine glycosylation.
    PLoS Biol. 2018;16:e2005817.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  46. AMITAI A, Chakraborty AK, Kardar M
    The low spike density of HIV may have evolved because of the effects of T helper cell depletion on affinity maturation.
    PLoS Comput Biol. 2018;14:e1006408.
    PubMed     Text format     Abstract available


    PLoS Med

  47. TANG W, Wei C, Cao B, Wu D, et al
    Crowdsourcing to expand HIV testing among men who have sex with men in China: A closed cohort stepped wedge cluster randomized controlled trial.
    PLoS Med. 2018;15:e1002645.
    PubMed     Text format     Abstract available


    PLoS One

  48. AYIEKO J, Brown L, Anthierens S, Van Rie A, et al
    "Hurdles on the path to 90-90-90 and beyond": Qualitative analysis of barriers to engagement in HIV care among individuals in rural East Africa in the context of test-and-treat.
    PLoS One. 2018;13:e0202990.
    PubMed     Text format     Abstract available

  49. MASKEW M, Jamieson L, Mohomi G, Long L, et al
    Implementation of Option B and a fixed-dose combination antiretroviral regimen for prevention of mother-to-child transmission of HIV in South Africa: A model of uptake and adherence to care.
    PLoS One. 2018;13:e0201955.
    PubMed     Text format     Abstract available

  50. NAIDOO N, Zuma N, Khosa NS, Marincowitz G, et al
    Qualitative assessment of facilitators and barriers to HIV programme implementation by community health workers in Mopani district, South Africa.
    PLoS One. 2018;13:e0203081.
    PubMed     Text format     Abstract available

  51. TREVILLYAN JM, Wong G, Puls R, Petoumenos K, et al
    Changes in plasma lipidome following initiation of antiretroviral therapy.
    PLoS One. 2018;13:e0202944.
    PubMed     Text format     Abstract available

  52. MUNUSAMY PONNAN S, Swaminathan S, Tiruvengadam K, K K V, et al
    Induction of circulating T follicular helper cells and regulatory T cells correlating with HIV-1 gp120 variable loop antibodies by a subtype C prophylactic vaccine tested in a Phase I trial in India.
    PLoS One. 2018;13:e0203037.
    PubMed     Text format     Abstract available

  53. MCNAIRY ML, Jannat-Khah D, Pape JW, Marcelin A, et al
    Predicting death and lost to follow-up among adults initiating antiretroviral therapy in resource-limited settings: Derivation and external validation of a risk score in Haiti.
    PLoS One. 2018;13:e0201945.
    PubMed     Text format     Abstract available

  54. LI H, Hai Y, Lim SY, Toledo N, et al
    Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques.
    PLoS One. 2018;13:e0202997.
    PubMed     Text format     Abstract available

  55. MINICK SG, May SB, Amico KR, Cully J, et al
    Participants' perspectives on improving retention in HIV care after hospitalization: A post-study qualitative investigation of the MAPPS study.
    PLoS One. 2018;13:e0202917.
    PubMed     Text format     Abstract available

  56. YOUNG CR, Kaida A, Kabakyenga J, Muyindike W, et al
    Prevalence and correlates of physical and sexual intimate partner violence among women living with HIV in Uganda.
    PLoS One. 2018;13:e0202992.
    PubMed     Text format     Abstract available

  57. CONSERVE DF, Muessig KE, Maboko LL, Shirima S, et al
    Mate Yako Afya Yako: Formative research to develop the Tanzania HIV self-testing education and promotion (Tanzania STEP) project for men.
    PLoS One. 2018;13:e0202521.
    PubMed     Text format     Abstract available

  58. SACCHI A, Tumino N, Grassi G, Casetti R, et al
    A new procedure to analyze polymorphonuclear myeloid derived suppressor cells in cryopreserved samples cells by flow cytometry.
    PLoS One. 2018;13:e0202920.
    PubMed     Text format     Abstract available

  59. ABEL S, Cuzin L, Da Cunha S, Bolivard JM, et al
    Reaching the WHO target of testing persons in jails in prisons will need diverse efforts and resources.
    PLoS One. 2018;13:e0202985.
    PubMed     Text format     Abstract available


  60. Retraction: A DNA inducing VLP vaccine designed for HIV and tested in mice.
    PLoS One. 2018;13:e0203635.
    PubMed     Text format    

  61. GICHANE MW, Moracco KE, Thirumurthy H, Okitolonda EW, et al
    Intimate partner violence and prevention of mother to child transmission of HIV: Evidence from Kinshasa, Democratic Republic of Congo.
    PLoS One. 2018;13:e0203471.
    PubMed     Text format     Abstract available

  62. KUMAR S, Gupte HA, Isaakidis P, Mishra JK, et al
    "They don't like us....": Barriers to antiretroviral and opioid substitution therapy among homeless HIV positive people who inject drugs in Delhi: A mixed method study.
    PLoS One. 2018;13:e0203262.
    PubMed     Text format     Abstract available

  63. CORREA-ROCHA R, Lopez-Abente J, Gutierrez C, Perez-Fernandez VA, et al
    CD72/CD100 and PD-1/PD-L1 markers are increased on T and B cells in HIV-1+ viremic individuals, and CD72/CD100 axis is correlated with T-cell exhaustion.
    PLoS One. 2018;13:e0203419.
    PubMed     Text format     Abstract available

  64. RABERAHONA M, Razafinambinintsoa T, Andriananja V, Ravololomanana N, et al
    Hospitalization of HIV positive patients in a referral tertiary care hospital in Antananarivo Madagascar, 2010-2016: Trends, causes and outcome.
    PLoS One. 2018;13:e0203437.
    PubMed     Text format     Abstract available

  65. SEEKAEW P, Pengnonyang S, Jantarapakde J, Sungsing T, et al
    Characteristics and HIV epidemiologic profiles of men who have sex with men and transgender women in key population-led test and treat cohorts in Thailand.
    PLoS One. 2018;13:e0203294.
    PubMed     Text format     Abstract available

  66. BROGAN AJ, Davis AE, Goodwin B
    Short-term cost analysis of raltegravir versus atazanavir + ritonavir or darunavir + ritonavir for treatment-naive adults with HIV-1 infection in the United States.
    PLoS One. 2018;13:e0203293.
    PubMed     Text format     Abstract available

  67. DA W, Li X, Qiao S, Zhou Y, et al
    Evaluation of self-report adherence measures and their associations with detectable viral load among people living with HIV (PLHIV) in China.
    PLoS One. 2018;13:e0203032.
    PubMed     Text format     Abstract available


    PLoS Pathog

  68. CHAUDHARY O, Narayan V, Lelis F, Linz B, et al
    Inhibition of p38MAPK in combination with ART reduces SIV-induced immune activation and provides additional protection from immune system deterioration.
    PLoS Pathog. 2018;14:e1007268.
    PubMed     Text format     Abstract available

  69. LERTJUTHAPORN S, Cicala C, Van Ryk D, Liu M, et al
    Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to alpha4beta7.
    PLoS Pathog. 2018;14:e1007278.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  70. ZHANG S, Tao F, Qing R, Tang H, et al
    QTY code enables design of detergent-free chemokine receptors that retain ligand-binding activities.
    Proc Natl Acad Sci U S A. 2018 Aug 28. pii: 1811031115.
    PubMed     Text format     Abstract available


    Virology

  71. ZICARI S, Arakelyan A, Palomino RAN, Fitzgerald W, et al
    Human cytomegalovirus-infected cells release extracellular vesicles that carry viral surface proteins.
    Virology. 2018;524:97-105.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: